These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. Beghi G; Berni F; Carratù L; Casalini A; Consigli G; D'Antò M; Gioia V; Molino A; Paizis G; Vaghi A J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122 [TBL] [Abstract][Full Text] [Related]
45. [Amoxicillin/clavulanic acid in therapy of bacterial infections of the diabetic foot. Results of an observational study]. Gerards V; Schiewe U; Gerards HH; Machka K; Höbel W; Meister W MMW Fortschr Med; 2000 Jan; 142(3 Suppl):187-94. PubMed ID: 10783611 [TBL] [Abstract][Full Text] [Related]
46. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis. Maesen FP; Davies BI; Baur C J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724 [TBL] [Abstract][Full Text] [Related]
47. Sensitization to amoxycillin in Augmentin. Kennedy C; Stolz E; van Joost T Contact Dermatitis; 1989 Apr; 20(4):313-4. PubMed ID: 2752748 [No Abstract] [Full Text] [Related]
48. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease. Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816 [TBL] [Abstract][Full Text] [Related]
49. Amoxicillin/clavulanate (Augmentin) resistant Escherichia coli in bacterial peritonitis after abdominal surgery--clinical outcome in ICU patients. Rahnama'i MS; Wagenvoort JH; van der Linden CJ Neth J Med; 2009 May; 67(5):173-6. PubMed ID: 19581666 [TBL] [Abstract][Full Text] [Related]
50. Activity of amoxycillin-clavulanic acid against Legionella pneumophila in vitro and in an experimental respiratory infection model. Smith GM; Sutherland R J Hosp Infect; 1992 Nov; 22 Suppl A():61-7. PubMed ID: 1362751 [TBL] [Abstract][Full Text] [Related]
51. Sequential therapy with i.v. and oral ofloxacin in lower respiratory tract infections: a comparative study. Feist H Infection; 1991; 19 Suppl 7():S380-3. PubMed ID: 1804787 [TBL] [Abstract][Full Text] [Related]
57. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis. Brook I Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313 [No Abstract] [Full Text] [Related]
58. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat. Catherall EJ; Irwin R; Mizen LW J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588 [TBL] [Abstract][Full Text] [Related]
59. Antibiotic therapy of perforated appendicitis in children: a comparison of amoxycillin/clavulanate with a combination of benzylpenicillin, netilmicin and metronidazole. Schmitt M; Bondonny JM; Delmas P; Galifer RB; Revillon Y; Robert M; Janin A J Antimicrob Chemother; 1989 Nov; 24 Suppl B():157-63. PubMed ID: 2691477 [TBL] [Abstract][Full Text] [Related]
60. Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice. Aronoff SC; Jacobs MR; Labrozzi PH; Yamabe S J Antimicrob Chemother; 1986 Aug; 18(2):271-6. PubMed ID: 3019987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]